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Abstract
BACKGROUND: Cognitive dysfunction is one of the characteristics of schizophrenia traditionally experienced by 
elderly patients. In the past 25 years, studies have proven that the cognitive dysfunction is an early characteristic of 
this disease, besides introversion, drug abuse, suicidal behavior, and depressive symptoms. The mini-mental state 
examination is a test designed to identify functional and organic disorders in psychiatric patients. North Sumatera 
is often considered as “small Indonesia” due to the variety of tribes live in the province; therefore, a study in relation 
with the cognitive profile of patients with schizophrenia (PwS) is needed.
AIM: We aimed to analyze cognitive function in PwS in the North Sumatera.
METHODS: The study was a descriptive study with a cross-sectional approach of cognitive profile of PwS stressing 
in the age, sex, education, and illness duration of the patients.
RESULTS: The results of the study using 200 subjects found that the most affected gender were male (62.5%), 
between the ages of 25–34 years (46%), with secondary school education background (55.5%), and with an illness 
duration >1 year (64.0%). The results showed that cognitive function in schizophrenic patients was probable cognitive 
dysfunction (56.5%).
CONCLUSIONS: From the results of this study, it was found that the most affected subjects were men, between 25 
and 34 years, with high school education, and the illness lasted more than 1 year. Most of the schizophrenic patients 
experienced probable cognitive dysfunction.
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Background
Schizophrenia is a severe psychiatric disorder 
with a multifactorial and complex etiology. The 
prevalence of schizophrenia is around 1% worldwide. 
This disorder usually appears on younger patients, 
though it is likely to appear on to all ages. Women and 
men stand the same chance of contacting this disease, 
though men tend to have onset earlier than women. The 
initial age for patients suffering from schizophrenics 
was between 10 and 25 years for men, and 25 and 
35 years for women. However, the current study has 
it that about 90% of patients receiving schizophrenia 
treatment are between the ages of 15 and 55 years of 
age [1].
Schizophrenia has a characteristic deficit in 
executive, memory, and general intellectual functions [2]. 
Some contrasting opinions about cognitive function in 
schizophrenia still exist. The first opinion suggests that 
cognitive deficits become progressively worse during 
the duration of the disease. As the symptom gradually 
develops, the patient’s intellectual function weakens, 
and they become socially abusive. The second opinion 
suggests that once the cognitive deficits appear, they 
will be relatively stable [3].
The mini-mental state examination (MMSE) was 
originally designed to provide a brief and standardized 
assessment of mental status that can distinguish 
between functional and organic disorders in psychiatric 
patients. Over the years, there has been an increase in 
the test experience; however, its recent main function 
is to detect and track the progression of cognitive 
function associated with neurocognitive disorders [4]. 
The previous studies proved that MMSE itself was used 
in the measurement of patients with schizophrenia 
(PwS) in the United States of America, Singapore, and 
other countries due to it short administration time and 
available in validated many languages [5]. The analysis 
of cognitive function in PwS has been frequently carried 
out in various parts of the world, and thus, due to the 
varieties of tribes in the North Sumatera, a study should 
be done as a specific study of its own.
Methods
This study was a descriptive study which 
uses a cross-sectional approach [6] to determine 
the profile of cognitive function in PwS in North 
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Sumatera Indonesia. The study subjects consisted of 
schizophrenic patients diagnosed according to the 10th 
edition of the International Classification of Disease 
and Related Health Problems (ICD-10). The diagnosis 
was made by a psychiatrist (MMA), and his colleagues 
(EE), and (BL) before the fulfillment of inclusion and 
exclusion criteria.
The study made use of the following inclusion 
criteria: (1) Outpatient schizophrenic who met the 
diagnostic criteria for ICD-10, (2) patients between 
the ages of 15–55 years old, (3) cooperative and 
interview-able patients, (4) those capable of speaking 
the Indonesian language, (5) patients who must 
have at least graduated from primary school, and 
(6) those willing to participate in the study, confirmed 
by signing consent to participate in the study both 
by subjects and their families, while the exclusion 
criteria used in carrying out this study were as 
follows: (1) Schizophrenic patients with comorbid 
diabetes mellitus and (2) patients with a history 
of stroke, transient ischemic attack, epilepsy, and 
Parkinson’s disease. We used the Indonesian version 
of MMSE that validated by Psychogeriatric Section on 
Psychogertaric of Indonesian Psychiatric Association; 
they divided the results of it into three categories: 
(1) Normal, (2) probable cognitive disorder, and (3) 
definite cognitive disorder, with the scores of 25-30 for 
normal, 18–24 for a probable cognitive disorder, and 
0–17 for a definite cognitive disorder, respectively. The 
study was done after the authors were granted ethical 
clearance from the Health Ethical Commission of the 
Faculty of Medicine, Universitas Sumatera Utara. All 
of the subjects that met the inclusion and exclusion 
criteria would undergo the MMSE by MMA and EE to 
determine their cognitive level.
Results
Characteristics of gender, age, educational 
background, and illness duration
From Table 1, it can be observed that men were 
more prone to this disease (62.5%), with an age range 
Table 1: Characteristics of gender, age, educational 
background, and illness duration
Respondents characteristic n %
Gender
Men 125 62.5
Women 75 37.5
Age
15–24 years old 18 9.0
25–34 years old 92 46.0
35–44 years old 66 33.0
45–55 years old 24 12.0
Background
Primary school 20 10.0
Secondary school 161 80.5
University 19 9.5
Illness duration (year)
≤1 72 36.0
>1 128 64.0
of 25–34 years (46%), secondary school education 
background (80.5%), and an illness duration >1 year 
(64.0%).
Cognitive function in schizophrenic 
patients
Table 2 showed that cognitive function in most 
schizophrenic patients was probable cognitive disorder 
(56.5%).
Table 2: Cognitive function in schizophrenic patients
MMSE-scoring n %
Normal 61 30,5
Probable cognitive disorder 113 56,5
Definite cognitive disorder 26 13,0
Discussion
A descriptive study with cross-sectional studies 
was used in carrying out this study. The results of the 
study using 200 subjects found that the most affected 
gender were male (62.5%), between the ages of 25 
and 34 years (46%), with secondary school education 
background (80.5%), and with an illness duration >1 
year (64.0%). Similar results were also found in the 
studies carried out by Kelly et al. [7], which found 
men to being the most affected. Talreja et al. [8] also 
found that every 100 schizophrenic subjects, 84% 
had cognitive dysfunction. In MMSE-scoring, when 
the total score is below 24, it should be considered as 
having probable cognitive dysfunction [9]. This study 
found that cognitive function in schizophrenic patients 
was probably cognitive impairment (56.5%), with a 
score range of 17–23. It is in line with the statement 
that schizophrenic patients have intellectual retentive 
abilities, even though certain cognitive deficits are likely 
to develop later [10]. Almost similar results were found in 
studies conducted by Fisekovic et al. [11], which found 
that MMSE scores in PwS were 24.9 ± 3.3 compared 
with our findings.
Age is considered to affect the cognitive 
dysfunction in schizophrenia, PwS was shown to have 
a deteriorated cognitive with increasing age compared 
to control [12]. In relation to sex, male PwS was found 
to experience serious cognitive deficits than female 
PwS [13]. The female PwS experienced better in 
immediate and delayed memory test [14]. These findings 
were supported by a study that was done, Zhang et al., 
as well [15]. According to a literature review made by 
Antonova et al. [16], the cognitive dysfunction in PwS 
was closely related to a decrease in gray matter density, 
temporal, and frontal lobe volume. Another research 
that supports this analysis was the study of Geisler 
et al. [17], which found that gray matter structure also had 
a relationship with cognitive dysfunction in people with 
schizophrenia. Some of the things that influence cognitive 
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dysfunction in PwS include episodes of illness [18] and 
Estrogen [19]. Cognitive dysfunction in schizophrenia 
also prolongs the duration of the disease, worsens social 
functions, and increases the rate at which patients are 
being hospitalized [20], and the longer duration of the 
illness will show more cognitive dysfunction [8].
The limitations of this study include the lack of 
research comparison of cognitive dysfunction between 
men and women living with schizophrenia, which was 
done in the ward setting and the use of MMSE instrument. 
The MMSE instrument is not specifically designed for 
people with schizophrenia. Thus, in the future, we need 
a better instrument that is designed to screen cognitive 
dysfunction in schizophrenia, specifically.
Conclusions
Schizophrenia is a mental illness, one of which 
causes a decline in cognitive function in patients. 
Cognitive functions are needed to work on tasks given, 
such as communicating and interacting with others, 
and in carrying out daily activities. Until now, there 
has not been a study to know exactly what causes 
schizophrenia and cognitive decline. However, it has 
been thought that several parts of the brain play a role 
in this matter.
For patients living with schizophrenia and 
who experience cognitive dysfunction, it is advisable 
to get additional therapy other than the medicines 
they consumed, as this would improve their cognitive 
function. Some therapies that can be done are cognitive 
remediation therapy and cognitive behavioral therapy, 
though these therapies do not have satisfactory results. 
Further, understanding and study are needed to find the 
exact cause and the right therapy to improve it.
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